Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Iron Oxide Colloidal Nanoclusters as Theranostic Vehicles and Their Interactions at the Cellular Level.

Kostopoulou A, Brintakis K, Fragogeorgi E, Anthousi A, Manna L, Begin-Colin S, Billotey C, Ranella A, Loudos G, Athanassakis I, Lappas A.

Nanomaterials (Basel). 2018 May 9;8(5). pii: E315. doi: 10.3390/nano8050315.

2.

On the use of superparamagnetic hydroxyapatite nanoparticles as an agent for magnetic and nuclear in vivo imaging.

Adamiano A, Iafisco M, Sandri M, Basini M, Arosio P, Canu T, Sitia G, Esposito A, Iannotti V, Ausanio G, Fragogeorgi E, Rouchota M, Loudos G, Lascialfari A, Tampieri A.

Acta Biomater. 2018 Jun;73:458-469. doi: 10.1016/j.actbio.2018.04.040. Epub 2018 Apr 22.

PMID:
29689381
3.

A prototype PET/SPECT/X-rays scanner dedicated for whole body small animal studies.

Rouchota M, Georgiou M, Fysikopoulos E, Fragogeorgi E, Mikropoulos K, Papadimitroulas P, Kagadis G, Loudos G.

Hell J Nucl Med. 2017 May-Aug;20(2):146-153. doi: 10.1967/s002449910556. Epub 2017 Jul 12.

4.

Versatile quarto stimuli nanostructure based on Trojan Horse approach for cancer therapy: Synthesis, characterization, in vitro and in vivo studies.

Efthimiadou EK, Fragogeorgi E, Palamaris L, Karampelas T, Lelovas P, Loudos G, Tamvakopoulos C, Kostomitsopoulos N, Kordas G.

Mater Sci Eng C Mater Biol Appl. 2017 Oct 1;79:605-612. doi: 10.1016/j.msec.2017.05.082. Epub 2017 May 13.

PMID:
28629059
5.

Characterization of "γ-Eye": a Low-Cost Benchtop Mouse-Sized Gamma Camera for Dynamic and Static Imaging Studies.

Georgiou M, Fysikopoulos E, Mikropoulos K, Fragogeorgi E, Loudos G.

Mol Imaging Biol. 2017 Jun;19(3):398-407. doi: 10.1007/s11307-016-1011-4.

PMID:
27730469
6.

Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivo.

Tsiapa I, Loudos G, Fragogeorgi EA, Bouziotis P, Psimadas D, Xanthopoulos S, Paravatou-Petsotas M, Palamaris L, Varvarigou AD, Karnabatidis D, Kagadis GC.

Cancer Biother Radiopharm. 2014 Dec;29(10):444-50. doi: 10.1089/cbr.2014.1672.

7.

Hollow microspheres based on - Folic acid modified - Hydroxypropyl Cellulose and synthetic multi-responsive bio-copolymer for targeted cancer therapy: controlled release of daunorubicin, in vitro and in vivo studies.

Metaxa AF, Efthimiadou EK, Boukos N, Fragogeorgi EA, Loudos G, Kordas G.

J Colloid Interface Sci. 2014 Dec 1;435:171-81. doi: 10.1016/j.jcis.2014.08.001. Epub 2014 Aug 23.

PMID:
25261841
8.

(99m)Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of ανβ3-mediated tumor expression and feasibility for hyperthermia treatment.

Tsiapa I, Efthimiadou EK, Fragogeorgi E, Loudos G, Varvarigou AD, Bouziotis P, Kordas GC, Mihailidis D, Nikiforidis GC, Xanthopoulos S, Psimadas D, Paravatou-Petsotas M, Palamaris L, Hazle JD, Kagadis GC.

J Colloid Interface Sci. 2014 Nov 1;433:163-175. doi: 10.1016/j.jcis.2014.07.032. Epub 2014 Aug 1.

PMID:
25128864
9.

In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticles.

Baldi G, Ravagli C, Mazzantini F, Loudos G, Adan J, Masa M, Psimadas D, Fragogeorgi EA, Locatelli E, Innocenti C, Sangregorio C, Comes Franchini M.

Int J Nanomedicine. 2014 Jun 24;9:3037-56. doi: 10.2147/IJN.S61273. eCollection 2014.

10.

Preliminary in vitro and in vivo evaluation of liposomal nanoparticles for passive and active tumour targeting by scintigraphic and MRI imaging.

Patrick B, Eirini F, Eleni E, Stavros X, Dimitrios P, Penelope B, George K, George L, Aime S.

EJNMMI Phys. 2014 Jul;1(Suppl 1):A82. doi: 10.1186/2197-7364-1-S1-A82. No abstract available.

11.

Comparative in vitro stability and scintigraphic imaging for trafficking and tumor targeting of a directly and a novel ⁹⁹mTc(I)(CO)₃ labeled liposome.

Fragogeorgi EA, Savina IN, Tsotakos T, Efthimiadou E, Xanthopoulos S, Palamaris L, Psimadas D, Bouziotis P, Kordas G, Mikhalovsky S, Alavijeh M, Loudos G.

Int J Pharm. 2014 Apr 25;465(1-2):333-46. doi: 10.1016/j.ijpharm.2014.01.042. Epub 2014 Feb 26.

PMID:
24583207
12.

Targeted delivery of silver nanoparticles and alisertib: in vitro and in vivo synergistic effect against glioblastoma.

Locatelli E, Naddaka M, Uboldi C, Loudos G, Fragogeorgi E, Molinari V, Pucci A, Tsotakos T, Psimadas D, Ponti J, Franchini MC.

Nanomedicine (Lond). 2014 May;9(6):839-49. doi: 10.2217/nnm.14.1. Epub 2014 Jan 17.

13.

Dynamic in vivo imaging of dual-triggered microspheres for sustained release applications: synthesis, characterization and cytotoxicity study.

Efthimiadou EK, Tapeinos C, Chatzipavlidis A, Boukos N, Fragogeorgi E, Palamaris L, Loudos G, Kordas G.

Int J Pharm. 2014 Jan 30;461(1-2):54-63. doi: 10.1016/j.ijpharm.2013.11.037. Epub 2013 Nov 25.

PMID:
24286923
14.

Biological evaluation of an ornithine-modified (99m)Tc-labeled RGD peptide as an angiogenesis imaging agent.

Tsiapa I, Loudos G, Varvarigou A, Fragogeorgi E, Psimadas D, Tsotakos T, Xanthopoulos S, Mihailidis D, Bouziotis P, Nikiforidis GC, Kagadis GC.

Nucl Med Biol. 2013 Feb;40(2):262-72. doi: 10.1016/j.nucmedbio.2012.10.015. Epub 2012 Dec 11.

PMID:
23238128
15.

Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort.

Duell EJ, Travier N, Lujan-Barroso L, Dossus L, Boutron-Ruault MC, Clavel-Chapelon F, Tumino R, Masala G, Krogh V, Panico S, Ricceri F, Redondo ML, Dorronsoro M, Molina-Montes E, Huerta JM, Barricarte A, Khaw KT, Wareham NJ, Allen NE, Travis R, Siersema PD, Peeters PH, Trichopoulou A, Fragogeorgi E, Oikonomou E, Boeing H, Schuetze M, Canzian F, Lukanova A, Tjønneland A, Roswall N, Overvad K, Weiderpass E, Gram IT, Lund E, Lindkvist B, Johansen D, Ye W, Sund M, Fedirko V, Jenab M, Michaud DS, Riboli E, Bueno-de-Mesquita HB.

Int J Cancer. 2013 May 1;132(9):2164-75. doi: 10.1002/ijc.27875. Epub 2012 Oct 30.

16.

Structural modifications of ⁹⁹mTc-labelled bombesin-like peptides for optimizing pharmacokinetics in prostate tumor targeting.

Liolios CC, Fragogeorgi EA, Zikos C, Loudos G, Xanthopoulos S, Bouziotis P, Paravatou-Petsotas M, Livaniou E, Varvarigou AD, Sivolapenko GB.

Int J Pharm. 2012 Jul 1;430(1-2):1-17. doi: 10.1016/j.ijpharm.2012.02.049. Epub 2012 Mar 10.

PMID:
22459664
17.

Spacer site modifications for the improvement of the in vitro and in vivo binding properties of (99m)Tc-N(3)S-X-bombesin[2-14] derivatives.

Fragogeorgi EA, Zikos C, Gourni E, Bouziotis P, Paravatou-Petsotas M, Loudos G, Mitsokapas N, Xanthopoulos S, Mavri-Vavayanni M, Livaniou E, Varvarigou AD, Archimandritis SC.

Bioconjug Chem. 2009 May 20;20(5):856-67. doi: 10.1021/bc800475k.

PMID:
19344122

Supplemental Content

Loading ...
Support Center